IFNL1 and psoriasis vulgaris: Additionally, IL-29 has been identified as a potent up-regulator of mRNA expression for key pro-inflammatory cytokines, including IL-6, IL-17, and TNF-α, in peripheral blood mononuclear cells (PBMCs) derived from psoriasis vulgaris patients (79).